Amesbury plc produces and distributes computer-controlled machinery. As accountant for the company, you have been provided with the following information regarding the company’s activities in researching and developing products in the year ended 31 October 1993:

(1) Expenditure on developing a new computerised tool for a long-established customer has amounted to £150 000. The work is now well advanced and the customer is likely to authorise the start of commercial production within the next 12 months. The customer is reimbursing Amesbury plc’s costs plus a 10% mark-up. To date the company has received £70 000 having invoiced £100 000 for agreed work done.

(2) A review of the company’s quality control procedures has been carried out at a cost of £100 000. It is considered that the new procedures will save a considerable amount of money in the testing and analysis of existing and new products.

(3) The development of Product M479 has reached an advanced stage. Costs in the year ended 31 October 1993 amounted to £400 000. In addition there has been expenditure on fixed assets required for the development of this product amounting to £120 000 of hich £60 000 was incurred in the year ended 31 October 1992. The fixed assets have a five-year life with no residual value and are depreciated on the straight-line basis with a full year’s depreciation in the year of acquisition.

Market research, costing £20 000, has been carried out and this indicates the product will be commercially viable although commercial production is unlikely to start until April 1994. The company expects that Product M479 will make a significant contribution to profit.

(4) Commercial production started on 1 June 1993 for Product A174. The costs of developing this product had been capitalised as follows:

£

Development expenditure capitalised as on 31 October 1992

200 000

Expenditure incurred in the year ended 31 October 1993

50 000

250 000

The company has taken out a patent which will last for ten years. The associated legal and administrative expenses amounted to £10 000.

Actual and estimated sales for Product A174:

Year ended 31 October

£

1993

250000

1994

750000

1995

1000000

1996

500000

1997

250000

After 31 October 1996 the company’s market share and profitability from the product are expected to diminish significantly due to the introduction of rival products by competitors.

(5) It is company policy to capitalise development expenditure wherever possible. Requirement

Prepare all relevant extracts of the published financial statements for the year ended 31 October 1993 in accordance with current accounting standards and legislation, explaining your treatment of items (1) to (4).

Note: You are not required to prepare extracts of the cash flow statement or the directors’ report.

"Get 15% discount on your first 3 orders with us"
Use the following coupon
"FIRST15"

Order Now